Tata India Pharma and Healthcare Fund
Direct · Growth ₹34.61
24 Apr 2026
NAV
18.0%
3Y CAGR
19.1%
5Y CAGR
13.4%
10Y CAGR
16.3%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
25.51
Sharpe
-19.8%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.38 L | 17.2% | -24.2% | 89.8% |
| 3 Years | ₹36.00 L | ₹47.68 L | 19.8% | -2.5% | 41.5% |
| 5 Years | ₹60.00 L | ₹99.93 L | 21.4% | 12.6% | 31.3% |
| 10 Years | ₹1.20 Cr | ₹3.03 Cr | 17.9% | 16.4% | 19.1% |
Fund SIP vs NIFTY 50
| Duration | Fund XIRR | Benchmark CAGR | Difference |
|---|---|---|---|
| 1 Year | 17.2% | -1.4% | +18.6% |
| 3 Years | 19.8% | 10.4% | +9.4% |
| 5 Years | 21.4% | 10.5% | +10.9% |
| 10 Years | 17.9% | 11.8% | +6.1% |